WHO expands options for HPV vaccination with Cecolin

FHS
October 7, 2024
10:37 am

WHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin has been confirmed for use in a single-dose schedule. The

Illumina competitor Element Biosciences raises $277M in Series D

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 12, 2024

Two type 1 diabetes patients now freed from insulin shots with cell therapy, Vertex reports

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin

June 23, 2023

Nurses, Resident Slashed; Deadly Tick Disease Outbreak; COVID Vax After Infection

Note that some links may require registration or subscription Two nurses and one medical resident at Newark Beth Israel Medical Center were slashed by a

December 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.